Adrenomedullin and the control of fluid and electrolyte homeostasis

Annual Review of Physiology

Volumn 61, Issue , 1999, Pages 363-389

  Samson, Willis K ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

Cardiovascular regulation; Natriuresis diuresis; Preproadrenomedullin; Proadrenomedullin N terminal 20 peptide; Renin angiotensin system; Vasoactive hormones

Indexed keywords

ADRENOMEDULLIN; ALDOSTERONE; ARGIPRESSIN; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CORTICOTROPIN; HORMONE RECEPTOR; NITRIC OXIDE; PROADRENOMEDULLIN;

ALDOSTERONE RELEASE; BRONCHOSPASM; CORTICOTROPIN RELEASE; ELECTROLYTE BALANCE; FLUID BALANCE; FLUID INTAKE; HEART PROTECTION; HORMONE RECEPTOR INTERACTION; HUMAN; KIDNEY BLOOD FLOW; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; SODIUM APPETITE; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION; VASOPRESSIN RELEASE;

ADRENOMEDULLIN; ANIMALS; BODY FLUIDS; ELECTROLYTES; HOMEOSTASIS; HUMANS; PEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTION, GENETIC;

EID: 0033029032     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.61.1.363     Document Type: Review

References (139)

1. 1. Samson WK. 1997. Cardiovascular hormones. In Endocrinology, Basic and Clinical Principles, ed. PM Conn, S Melmed, 361-76. Totowa, NJ: Humana. 448 pp.
2. 2. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, et al. 1993. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:553-60
3. 3. Kapas S, Catt KJ, Clark AJL. 1995. Cloning and expression of cDNA encoding a rat adrenomedullin receptor. J. Biol. Chem. 270:25344-47
4. 4. Smith DG, Owji AA, Coppock HA, Taylor GM, Ghatei MA, Bloom SR. 1998. Characterization of adrenomedullin receptor binding. Presented at 1st Intl. Symp. AM and PAMP, Osaka, Japan
5. 5. Kitamura K, Sakata J, Kangawa K, Kojima H, Matsuo H, Eto T. 1993. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem. Biophys. Res. Commun. 194: 720-25
6. 6. Ishimitsu T, Kojima M, Hino J, Matsuoka H, Kitamura K, et al. 1994. Genomic structure of human adrenomedullin gene. Biochem. Biophys. Res. Commun. 203:631-39
7. 7. Sakata J, Shimokubo T, Kitamura K, Nakamura S, Kangawa K, et al. 1994. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem. Biophys. Res. Commun. 195:921-27
8. 8. Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T. 1994. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 338:6-10
9. 9. Satoh F, Takahashi K, Murakami O, Totsune K, Sone M, et al. 1996. Immunocytochemical localization of adrenomedullin-like immunoreactivity in the human hypothalamus and adrenal gland. Neurosci. Lett. 203:207-10
10. 10. Washimine H, Asada Y, Kitamura K, Ichiki Y, Hara S, et al. 1995. Immunohistochemical identification of adrenomedullin in human, rat, and porcine tissue. Histochem. Cell. Biol. 103:251-54
11. 11. Sakata J, Shimokubo T, Kitamura K, Nakamura S, Kangawa K, et al. 1994. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS Lett. 352:105-8
12. 12. Ueta Y, Kitamura K, Isse T, Shibuya I, Kabashima N, et al. 1995. Adrenomedullin-immunoreactive neurons in the paraventricular and supraoptic nuclei of the rat. Neurosci. Lett. 202:37-40
13. 13. Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, et al. 1994. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem. Biophys. Res. Commun. 201:1160-66
14. 14. Minamino N, Shoji H, Sugo S, Kangawa K, Matsuo H. 1995. Adrenocortical steroids, thyroid hormones and retinoic acid augment the production of adrenomedullin in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 211:686-93
15. 15. Sugo S, Minamino N, Shoji H, Kangawa K, Matsuo H. 1995. Effects of vasoactive substances and cAMP related compounds on adrenomedullin production in cultured vascular smooth muscle cells. FEBS Lett. Lett. 369:311-14
16. 16. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, et al. 1995. Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 207:25-32
17. 17. Chun TH, Itoh H, Ogawa Y, Tamura N, Takaya K, et al. 1997. Shear stress augments expression of C-type natriuretic peptide and adrenomedullin. Hypertension 29:1296-1302
18. 18. Jougasaki M, Wei CM, Mckinley LJ, Burnett JC. 1995. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 92:286-89
19. 19. Satoh F, Takahashi K, Murakami O, Totsune K, Sone M, et al. 1995. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma. J. Clin. Endocrinol. Metab. 80:1750-52
20. 20. Katoh F, Kitamura K, Niina H, Yamamoto R, Washimine H, et al. 1995. Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide: its exocytotic secretion and inhibition of catecholamine secretion in adrenal medulla. J. Neurochem. 64:459-61
21. 21. Romppanen H, Marttila M, Magga J, Vuolteenaho O, Kinnunen P. 1997. Adrenomedullin gene expression in the rat heart is stimulated by acute pressure overload: blunted effect in experimental hypertension. Endocrinology 138:2636-39
22. 22. Jougasaki M, Wei CM, Aarhus LL, Heublein DM, Sandberg SM, Burnett JC. 1995. Renal localization and actions of adrenomedullin: a natriuretic peptide. Am. J. Physiol. 268:F657-63
23. 23. Kitamura K, Ichiki Y, Tanaka M, Kawamoto M, Emura J, et al. 1994. Immunoreactive adrenomedullin in human plasma. FEBS Lett. 341:288-90
24. 24. Sato K, Hirata Y, Imai T, Iwashina M, Marumo F. 1995. Characterization of immunoreactive adrenomedullin in human plasma and urine. Life Sci. 57:189-94
25. 25. Washimine H, Yamamoto Y, Kitamura K, Tanaka M, Ichiki Y, et al. 1995. Plasma concentrations of human adrenomedullin in patients on hemodialysis. Clin. Nephrol. 44:389-93
26. 26. Meeran K, O'Shea D, Upton PD, Small CJ, Ghatei MA, et al. 1997. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. J. Clin. Endocrinol. Metab. 82:95-100
27. 27. Isumi Y, Shoji H, Sugo S, Tochimoto T, Yoshioka M, et al. 1998. Regulation of adrenomedullin production in rat endothelial cells. Endocrinology 139:838-46
28. 28. Katoh F, Niina H, Kitamura K, Ichiki Y, Yamamoto Y, et al. 1994. Calcium-dependent cosecretion of adrenomedullin and catecholamines mediated by nicotinic receptors in bovine adrenal medullary cells. FEBS Lett. 348:61-64
29. 29. Sato K, Imai T, Iwashima M, Marumo F, Hirata Y. 1998. Secretion of adrenomedullin by renal tubular cell lines. Nephron 78:9-14
30. 30. Nishikimi T, Kitamura K, Saito Y, Shimada K, Ishimitsu T, et al. 1994. Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension 24:600-4
31. 31. Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, et al. 1994. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J. Clin. Invest. 94:2158-61
32. 32. Kohno M, Hanehira T, Kano H, Horio T, Yokokawa K, et al. 1996. Plasma adrenomedullin concentrations in essential hypertension. Hypertension 27:102-7
33. 33. Shimokubo T, Sakata J, Kitamura K, Kangawa K, Matsuo H, Eto T. 1995. Augmented adrenomedullin concentrations in right ventricle and plasma of experimental pulmonary hypertension. Life Sci. 57:1771-79
34. 34. Nisikimi T, Nagata S, Sasaki T, Tomimoto S, Matsuoka H, et al. 1997. Plasma concentrations of adrenomedullin correlate with the extent of pulmonary hypertension in patients with mitral stenosis. Heart 78:390-95
35. 35. Hamada M, Shigematsu Y, Kawakami H, Minamino N, Kangawa K, et al. Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy: its relation to endothelin-1, natriuretic peptide, and noradrenaline. Clin. Sci. Colch. 94:21-28
36. 36. Miyao Y, Nishikimi T, Goto Y, Miyazaki S, Daikoku S, et al. 1998. Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity. Heart 79:39-44
37. 37. Cheung B, Leung R. 1997. Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. Clin. Sci. 92:59-62
38. 38. Guevara M, Gines P, Jimenez W, Sort P, Fernandez-Esparrach G, et al. 1998. Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems. Gastroenterology 114:336-43
39. 39. Taniyama M, Kitamura K, Ban Y, Sigita E, Ito K, Katagiri T. 1997. Elevation of circulating proadrenomedullin N-20 terminal peptide in thyrotoxicosis. Clin. Endocrinol. 46:271-74
40. 40. Kohno M, Hanehira T, Hirata K, Kawaguchi T, Okishio K, et al. 1996. An accelerated increase of plasma adrenomedullin in acute asthma. Metabolism 45:1323-25
41. 41. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, et al. 1996. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J. Clin. Endocrinol. Metab. 81:1449-53
42. 42. Nishio K, Akai Y, Murao Y, Doi N, Ueda S. 1997. Increased plasma concentration of adrenomedullin correlates with relaxation of vascular tone in patients with septic shock. Crit. Care Med. 25:953-57
43. 43. Parkes DG, May CN. 1997. Direct cardiac and vascular actions of adrenomedullin in conscious sheep. Br. J. Pharmacol. 120: 1179-85
44. 44. Samson WK, Murphy TC, Resch ZT. 1998. Central mechanisms for the hypertensive effects of preproadrenomedullin derived peptides in conscious rats. Am. J. Physiol. 274:R1505-9
45. 45. Nishikimi T, Horio T, Sasaki T, Yoshihara F, Takishita S, et al. 1997. Cardiac production and secretion of adrenomedullin are increased in heart failure. Hypertension 30:1369-75
46. 46. Jougasaki M, Stevens L, Borgeson DD, Luchner A, Redfield MM, Burnett JC. 1997. Adrenomedullin in experimental congestive heart failure: cardiorenal activation. Am. J. Physiol. 273:R1392-99
47. 47. Ishimitsu T, Miyata A, Matsuoka H, Kangawa K. 1998. Transcriptional regulation of human adrenomedullin gene in vascular endothelial cells. Biochem. Biophys. Res. Commun. 243:463-70
48. 48. Shoji H, Minamino N, Kangawa K, Matsuo H. 1995. Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat. Biochem. Biophys. Res. Commun. 215: 531-37
49. 49. Tsuruda T, Kato J, Kitamura K, Kuwasako K, Imamura T, et al. 1998. Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension 31:505-10
50. 50. Takahashi K, Satoh F, Hara E, Sone M, Murakami O, et al. 1997. Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP production. Peptides 18:1117-24
51. 51. Kuchinke W, Hart RP, Jonakait GM. 1995. Identification of mRNAs regulated by interferon-gamma in cultured rat astrocytes by PCR differential display. Neuroimmunomodulation 2:347-55
52. 52. Baskaya M, Suzuki Y, Anzai M, Seki Y, Saito K, et al. 1995. Effects of adrenomedullin, calcitonin gene-related peptide, and amylin on cerebral circulation in dogs. J. Cereb. Blood Flow Metab. 15:827-34
53. 53. Mori T, Takayasu M, Suzuki Y, Shibuya M, Yoshida J, Hidaka H. 1997. Effects of adrenomedullin on rat cerebral arterioles. Eur. J. Pharmacol. 330:195-98
54. 54. Lang MG, Paterno R, Faraci FM, Heistad DD. 1997. Mechanisms of adrenomedullin induced dilatation of cerebral arterioles. Stroke 28:181-85
55. 55. Berthiaume N, Claing A, Lippton H, Cadieux A, D'Orleans-Juste P. 1995. Rat adrenomedullin induces selective arterial vasodilation via CGRP1 receptors in the double perfused mesenteric bed of the rat. Can. J. Physiol. Pharmacol. 73:1080-83
56. 56. Nuki C, Kawasaki H, Kitamura K, Takenaga M, Kangawa K. 1993. Vasodilator effect of adrenomedullin and calcitonin gene related peptide receptors in rat mesenteric vascular beds. Biochem. Biophys. Res. Commun. 196:245-51
57. 57. Nandha KA, Taylor GM, Smith DM, Owji AA, Byfield PG, et al. 1995. Specific binding sites and hypotension in the rat systemic vascular bed. Regul. Pept. 62: 145-51
58. 58. Haynes JM, Cooper ME. 1995. Adrenomedullin and calcitonin gene related peptide in the rat isolated kidney and the anesthetized rat: in vitro and in vivo effects. Eur. J. Pharmacol. 280: 91-94
59. 59. Hjelmqvist H, Keil R, Mathai M, Hubschle T, Gertsberger R. 1997. Vasodilation and glomerular binding of adrenomedullin in rabbit kidney are not CGRP receptor mediated. Am. J. Physiol. 273:R716-24
60. 60. Gardiner SM, Kemp PA, March JE, Bennett T. 1995. Regional hemodynamic effects of human and rat adrenomedullin in conscious rats. Br. J. Pharmacol. 114: 584-91
61. 61. Aiyar H, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, et al. 1996. A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J. Biol. Chem. 271: 11325-29
62. 62. Owji AA, Smith DM, Coppock HA, Morgan DGA, Bhogal R, et al. 1995. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology 136:2127-34
63. 63. Shimekake Y, Nagata K, Ohta S, Kambayashi Y, Teraoka H, et al. 1995. Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation, and calcium mobilization, in bovine aortic endothelial cells. J. Biol. Chem. 270:4412-17
64. 64. Samson WK, Murphy TC, Schell DA. 1995. A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release. Endocrinology 136: 2349-52
65. 65. Iwasaki H, Hirata Y, Iwashina M, Sato K, Marumo F. 1996. Specific binding for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat. Endocrinology 137:3045-50
66. 66. Ruskoaho H, Szokodi I, Kinnunen P, Romppanen H, Tavi P. 1998. Cardiac synthesis and effects of adrenomedullin. Presented at 1st Intl. Symp. AM and PAMP, Osaka, Japan
67. 67. Chini EN, Choi E, Grande JP, Burnett JC, Douse TP. 1995. Adrenomedullin suppresses mitogenesis in rat mesangial cells via cAMP pathway. Biochem. Biophys. Res. Commun. 215:868-73
68. 68. Hirata Y, Iwasaki H, Eguchi S. 1998. Role of adrenomedullin as a growth factor and its signal transduction in vascular smooth muscle cells. Presented at 1st Intl. Symp. AM and PAMP, Osaka, Japan
69. ATP channels. J. Surg. Res. 67:163-68
70. 70. Okamura T, Ayajiki K, Kangawa K, Toda N. 1997. Mechanism of adrenomedullin-induced relaxation in isolated canine retinal arteries. Invest. Ophthalmol. Vis. Sci. 38:56-61
71. 71. Kadowitz PJ, Bivalacqua TJ, McNamara DB, Champion HC. 1998. Analysis of pulmonary and peripheral responses to adrenomedullin and proadrenomedullin N-terminal 20 peptide inthe cat and rat. Presented at 1st Intl. Symp. AM and PAMP, Osaka, Japan
72. 2-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings. J. Clin. Invest. 96:1672-76
73. 73. Takano K, Yamashita N, Fujita T. 1996. Proadrenomedullin N-terminal 20 peptide inhibits the voltage-gated calcium channel current through a pertussis toxin-sensitive G protein in rat pheochromocytoma-derived PC12 cells. J. Clin. Invest. 98:14-17
74. 74. Samson WK, Murphy TC, Resch ZT. 1998. Proadrenomedullin N-20 terminal peptide inhibits basal adrenocorticotropin release in vitro. Endocrine. In press
75. 75. Samson WK, Murphy TC. 1996. Adrenomedullin inhibits salt appetite. Endocrinology 138:613-16
76. 76. Chao J, Jin L, Chao L. 1997. Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats. Hypertens. Res. 20:269-77
77. 77. Kurihara H, Shindo T, Maemura K, Kurihara Y, Kuwaki T, et al. 1998. Transgenic mice overexpressing adrenomedullin in vasculature. Presented at 1st Intl. Symp. on AM and PAMP, Osaka, Japan
78. 78. Murphy TC, Samson WK. 1995. The novel vasoactive hormone, adrenomedullin, inhibits water drinking in the rat. Endocrinology 136:2459-63
79. 79. Rademaker MT, Charles CJ, Lewis LK, Yandle TG, Cooper GJ, et al. 1997. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation 96:1983-90
80. 80. Ebara T, Mura K, Okumura M, Matsuura T, Kim S, et al. 1994. Effect of adrenomedullin on renal hemodynamics and functions in dogs. Eur. J. Pharmacol. 263:69-73
81. 81. Miura K, Ebara T, Okumura M, Matsuura T, Kim S, et al. 1995. Attenuation of adrenomedullin-induced renal vasodilation by NG-nitro-L-arginine but not glibenclamide. Br. J. Pharmacol. 115: 917-24
82. 82. Elhawary AM, Poon J, Pang CC. 1995. Effects of calcitonin gene related peptide antagonists on renal actions of adrenomedullin. Br. J. Pharmacol. 115: 1133-40
83. 83. Vari RC, Adkins SD, Samson WK. 1995. Renal effects of adrenomedullin in the rat. Proc. Soc. Exp. Biol. Med. 211:178-83
84. 84. Hirata Y, Hayakawa H, Suzuki Y, Suzuki Y, Ikenouchi H, et al. 1995. Mechanisms of adrenomedullin-induced vasodilation in the rat kidney. Hypertension 25:790-95
85. 85. Lainchbury JG, Cooper GJ, Coy DH, Jiang NY, Lewis LK, et al. 1997. Adrenomedullin: a hypotensive hormone in man. Clin. Sci. 92:467-72
86. 86. Seguchi H, Nishimura J, Kobayashi S, Kumazawa J, Kanaide H. 1995. Autocrine regulation of the renal arterial tone by adrenomedullin. Biochem. Biophys. Res. Commun. 215:619-25
87. 87. Jougasaki M, Aarhus LL, Heublein DM, Sandberg SM, Burnett JC. 1997. Role of prostaglandins and renal nerves in the renal actions of adrenomedullin. Am. J. Physiol. 272:F260-66
88. 88. Owada A, Nonoguchi H, Terada Y, Marumo F, Tomita K. 1997. Microlocalization and effects of adrenomedullin in nephron segments and in mesangial cells of the rat. Am. J. Physiol. 272:F691-97
89. 89. Togawa M, Haneda M, Araki S, Sugimoto T, Isono M, et al. 1997. Beraprost sodium, an analogue of prostacyclin, induces the expression of mitogen-activated protein kinase phosphatase and inhibits the proliferation of cultured mesangial cells. Eur. J. Pharmacol. 336:291-94
90. 90. Kohno M, Yasunari Y, Yokokawa K, Horio T, Ikeda M, et al. 1996. Interaction of adrenomedullin and platelet-derived growth factor on the production of endothelin. Hypertension 27:663-67
91. 91. Chini EN, Chini CC, Bolliger C, Jougasaki M, Grande JP, et al. 1997. Cytoprotective effects of adrenomedullin in glomerular cell injury: central role of cAMP signaling pathway. Kidney Int. 52:917-25
92. 92. Jensen BL, Kramer BK, Kurtz A. 1997. Adrenomedullin stimulates renin release and renin mRNA in mouse juxtaglomerular granular cells. Hypertension 29:1148-55
93. 93. Nussdorfer GG, Rossi GP, Mazzochi G. 1997. Role of adrenomedullin and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 18:1079-89
94. 94. Andreis PG, Neri G, Prayer-Galetti T, Rossi GP, Gottardo, et al. 1997. Effects of adrenomedullin on the human adrenal glands: an in vitro study. J. Clin. Endocrinol. Metab. 82:1167-70
95. 95. Andreis PG, Mazzocchi G, Rebuffat P, Nussdorfer GG. 1997. Effects of adrenomedullin and proadrenomedullin N-terminal 20 peptide on rat zona glomerulosa cells. Life Sci. 60:1693-97
96. 96. Yamaguchi T, Baba K, Doi Y, Yano K. 1995. Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells. Life Sci. 56:379-87
97. 97. Yamaguchi T, Baba K, Doi Y, Yano K, Kitamura K, Eto T. 1996. Inhibition of aldosterone production by adrenomedullin, a hypotensive peptide, in the rat. Hypertension 28:308-14
98. 98. Mazzocchi G, Rebuffat P, Gottardo G, Nussdorfer GG. 1996. Adrenomedullin and calcitonin gene-related peptide inhibit aldosterone secretion in rats, acting via a common receptor. Life Sci. 58:839-44
99. 99. Parkes DG, May CN. 1995. ACTH-suppressive and vasodilator actions of AM in conscious sheep. J. Neuroendocrinol. 7:923-29
100. 100. Kobayashi H, Yamamoto R, Niina H, Katoh F, Kuwasako K, et al. 1998. Adrenomedullin and PAMP in adrenal chromaffin cells. Presented at 1st Intl. Symp. AM and PAMP, Osaka, Japan
101. 101. Feng CJ, Kang B, Kaye AD, Kadowitz PJ, Nossman BD. 1994. L-NAME modulates responses to adrenomedullin in the hindquarters vascular bed of the rat. Life Sci. 55:433-38
102. 102. Fukuhara M, Tsuchihashi T, Abe I, Fujishima M. 1995. Cardiovascular and neurohumoral effects of intravenous adrenomedullin in conscious rabbits. Am. J. Physiol. 269:R1289-93
103. 103. Nakamura M, Yoshida H, Makita S, Arakawa N, Niinuma H, Hiramori K. 1997. Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure. Circulation 95:1214-21
104. 104. Parkes DG. 1995. Cardiovascular actions of adrenomedullin in conscious sheep. Am. J. Physiol. 268:H2574-78
105. 105. Shirai M, Shimouchi A, Ikeda S, Ninomiya I, Sunagawa K, et al. 1997. Vasodilator effects of adrenomedullin on small pulmonary arteries and veins in anesthetized cats. Br. J. Pharmacol. 121:679-86
106. 106. Champion HC, Akers DL, Santiago JA, Lambert DG, McNamara DB, Kadowitz PJ. 1997. Analysis of responses to human adrenomedullin and calcitonin gene-related peptides in the hindlimb vascular bed of the cat. Mol. Cell. Biochem. 176:5-11
107. 107. Barber DA, Park YS, Burnett JC, Miller VM. 1997. Adrenomedullin-mediated relaxations in veins are endothelium-dependent and distinct from arteries. J. Cardiovasc. Pharmacol. 30:695-701
108. 108. Champion HC, Lambert DG, McWilliams SM, Shah MK, Murphy WA, et al. 1997. Comparison of responses to rat and human adrenomedullin in the hindlimb vascular bed of the cat. Regul. Pept. 70:161-65
109. 2-terminal 20 peptide has direct vasodilator activity in the cat. Am. J. Physiol. 272:R1047-54
110. 110. Kano H, Kohno M, Yasunari K, Yokokawa K, Horio T, et al. 1996. Adrenomedullin as a novel antiproliferative factor in vascular smooth muscle cells. J. Hypertension 14:209-13
111. 111. Kohno M, Yokokawa K, Kano H, Yasunari K, Minami M, et al. 1997. Adrenomedullin is a potent inhibitor of angiotensin II induced migration of human coronary artery smooth muscle cells. Hypertension 29:1309-13
112. 112. Kohno M, Yasunari K, Yokokawa K, Minami M, Kano H, et al. 1998. Interaction of adrenomedullin and lysophosphatidylcholine, a major phospholipid component of atherogenic lipoproteins, on human coronary artery smooth muscle cell migration. Presented at 1st Intl. Symp. AM and PAMP, Osaka, Japan
113. 113. Itoh H, Nakao K. 1998. Adrenomedullin and vascular stress response. Presented at 1st Intl. Symp. AM and PAMP, Osaka, Japan
114. 114. Kato H, Shichiri M, Marumo F, Hirata Y. 1997. Adrenomedullin as an autocrine/paracrine survival factor for rat endothelial cells. Endocrinology 138: 2615-20
115. 115. Minamino N, Isumi Y, Kubo A, Katafuchi T, Tomoda Y, et al. 1998. Production of adrenomedullin in vascular cells, fibroblasts and macrophages. Presented at 1st Intl. Symp. AM and PAMP, Osaka, Japan
116. 116. Nishimori T, Tsujino M, Sato K, Imai T, Marumo F, Hirata Y. 1997. Dexamethasone-induced up-regulation of adrenomedullin and atrial natriuretic peptide genes in cultured rat ventricular myocytes. J. Mol. Cell. Cardiol. 29:2125-30
117. 117. Inatsu H, Sakata J, Shimokubo T, Kitani M, Nishizoni M, et al. 1996. Distribution and characterization of rat immunoreactive proadrenomedullin N-terminal 20 peptide (PAMP) and the augmented cardiac PAMP in spontaneously hypertensive rat. Biochem. Mol. Biol. Int. 38:365-72
118. 118. Sato A, Autelitano DJ. 1995. Adrenomedullin induces expression of c-fos and AP-1 activity in rat vascular smooth muscle cells and cardiomyocytes. Biochem. Biophys. Res. Commun. 217:211-16
119. 119. Sato A, Canny BJ, Autelitano DJ. 1997. Adrenomedullin stimulates cAMP accumulation and inhibits atrial natriuretic peptide gene expression in cardiomyocyte. Biochem. Biophys. Res. Commun. 230:311-14
120. 120. Nishikimi T, Horio T, Yoshihara N, Nagaya N, Matuo M, Kangawa K. 1998. Adrenomedullin in failing heart. Presented at 1st Intl. Symp. AM and PAMP, Osaka, Japan
121. 121. Szokodi I, Kinnunen P, Ruskoaho H. 1996. Inotropic effect of AM in the isolated perfused rat heart. Acta Physiol. Scand. 156:151-52
122. 122. Yang BC, Lippton H, Gumusel B, Hyman A, Mehta JL. 1996. Adrenomedullin dilates rat pulmonary artery rings during hypoxia: role of nitric oxide and vasodilator prostaglandins. J. Cardiovasc. Pharmacol. 28:458-62
123. 123. Kamoi H, Kanazawa K, Hirata K, Kurihara N, Yano Y, Otani S. 1995. Adrenomedullin inhibits the secretion of cytokine induced neutrophil chemoattractant, a member of the interleukin-8 family, from rat alveolar macrophages. Biochem. Biophys. Res. Commun. 211:1031-35
124. 124. Mulder H, Ahren B, Karlsson S, Sundler F. 1996. Adrenomedullin: localization in the gastrointestinal tract and effects on insulin secretion. Regul. Pept. 62:107-12
125. 125. Cornish J, Callon KE, Coy DH, Jiang NY, Xiao L, et al. 1997. Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo. Am. J. Physiol. 273:E1113-20
126. 126. Takahashi K, Satoh F, Sone M, Murakami O, Sasano H, et al. 1997. Expression of adrenomedullin mRNA in human brain and pituitary. Peptides 18:1051-53
127. 127. Montuenga LM, Burrell M, Garayoa M, Garcia D, Martinez A, et al. 1998. Expression of proadrenomedullin N-terminal 20 peptide in mammalian pituitary. Presented at 1st Intl. Symp. AM and PAMP, Osaka, Japan
128. 128. Yokoi H, Arima T, Kondo K, Iwasaki Y, Oiso Y. 1996. Intracerebroventricular injection of adrenomedullin inhibits vasopressin release in conscious rats. Neurosci. Lett. 216:65-67
129. 129. Samson WK. 1985. Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release. Neuroendocrinology 40:277-79
130. 130. Antunes-Rodrigues J, McCann SM, Rogers LC, Samson WK. 1985. Atrial natriuretic factor inhibits dehydration-and angiotensin II-induced water intake in the conscious, unrestrained rat. Proc. Natl. Acad. Sci. USA 82:8720-23
131. 131. Antunes-Rodrigues J, McCann SM, Samson WK. 1986. Central administration of atrial natriuretic factor inhibits saline preference in the rat. Endocrinology 118: 1726-28
132. 132. Dogan A, Suzuki Y, Koketsu N, Osuka K, Saito K, et al. 1997. Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 17:19-25
133. 133. Zimmerman U, Fischer JA, Frei K, Fischer AH, Reinscheid RK, Muff R. 1996. Identification of adrenomedullin receptors in cultured rat astrocytes and in neuroblastoma x glioma hybrid cells (NG108-15). Brain Res. 724:238-45
134. 134. Yeung VT, Ho SK, Nicholls MG, Cockram CS. 1996. Adrenomedullin, a novel vasoactive hormone, binds to mouse astrocytes and stimulates cyclic AMP production. J. Neurosci Res. 46:330-35
135. 135. Moody TW, Miller MJ, Martinez A, Unsworth E, Cuttitta F. 1997. Adrenomedullin binds with high affinity, elevates cAMP, and stimulates c-fos mRNA in C6 glioma cells. Peptides 18:1111-15
136. 136. Takahashi H, Watanabe T, Nishimura M, Nakanishi T, Sakamoto M, et al. 1994. Centrally induced vasopressor and sympathetic responses to a novel endogenous peptide, adrenomedullin, in anesthetized rats. Am. J. Hypertension 7:478-82
137. 137. Allen MA, Ferguson AV. 1996. In vitro recordings from area postrema neurons demonstrate responsiveness to adrenomedullin. Am. J. Physiol. 270:R920-92
138. 138. Allen MA, Smith PA, Ferguson AV. 1997. Adrenomedullin microinjection into the area postrema increases blood pressure. Am. J. Physiol. 272:R1698-1703
139. 139. Martinez V, Cuttitta F, Tache Y. 1997. Central action of adrenomedullin to inhibit gastric emptying in rats. Endocrinology 138:3749-55